Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis
IntroductionMultiple sclerosis (MS) is a potentially disabling disease that damages the brain and spinal cord, inducing paralysis of the body. While MS has been known as a T-cell mediated disease, recent attention has been drawn to the involvement of B cells in its pathogenesis. Autoantibodies from...
Κύριοι συγγραφείς: | Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, Yoe-Sik Bae |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Frontiers Media S.A.
2023-06-01
|
Σειρά: | Frontiers in Immunology |
Θέματα: | |
Διαθέσιμο Online: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151511/full |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
ανά: Michael Basler, κ.ά.
Έκδοση: (2014-01-01) -
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
ανά: Leonie Stolz, κ.ά.
Έκδοση: (2017-07-01) -
Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior
ανά: Pece Kocovski, κ.ά.
Έκδοση: (2021-06-01) -
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
ανά: Kaili Lu, κ.ά.
Έκδοση: (2020-02-01) -
Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects
ανά: Jeong Hyo-Soon, κ.ά.
Έκδοση: (2011-08-01)